06

2014-06

Notice of the First Extraordinary General Meeting of Shareholders 2010

Dear Shareholders and Shareholder Proxies: According to the resolution of the 10th meeting of the 3rd Board of Directors of Hunan Zhengqing Pharmaceutical Group Co., Ltd. on September 26, 2009, it was decided to convene the First Extraordinary General Meeting of Shareholders for the year 2010. The relevant matters are hereby notified as follows: I. Matters to be reviewed at this Extraordinary General Meeting of Shareholders: (I) Review the report from the company's Board of Directors, "Regarding the Reorganization and Development Plan of Zhengqing Group," and submit it to the General Meeting of Shareholders for voting and approval. (II) Review the company's proposal, "Regarding the Introduction of Strategic Investors, Disposal of Zhengqing Group's Debt to Agricultural Bank, and Reorganization of Zhengqing Group," and submit it to the General Meeting of Shareholders for voting and approval. (III) Review the proposal, "Regarding the Prompt Resumption of Intravenous Drip Product Houttuynia Cordata Injection," and submit it to the General Meeting of Shareholders for voting and approval. (IV) Review the proposal, "Regarding Cooperating with Huaihua Municipal Government to Actively Operate 'Xiangxi Traditional Chinese Medicine Valley' and 'Traditional Chinese Medicinal Materials Logistics Center'," and submit it to the General Meeting of Shareholders for voting and approval. (V) Review the proposal, "Regarding Reducing Shares Held in Huaihua Zhenghao Pharmaceutical Co., Ltd.," and submit it to the General Meeting of Shareholders for voting and approval. (VI) Review the proposal, "Regarding Converting Debt of China Hi-Tech Investment Group Corporation into Equity," and submit it to the General Meeting of Shareholders for voting and approval. For this General Meeting of Shareholders, the company will entrust lawyers to attend and issue legal opinions. II. Attendees of the Meeting: (I) All shareholders or shareholder proxies registered as of January 31, 2010 (the shareholder proxy does not necessarily have to be a company shareholder). (II) Company Directors, Supervisors, Board Secretaries, and other Senior Management personnel. (III) Lawyers appointed by the company and other personnel invited by the company's Board of Directors. III. Method of Attending the Meeting: (I) State-owned share shareholders shall register with a copy of the legal entity registration certificate from the state-owned asset management department or state-authorized shareholding unit (with official seal), and legal entity share shareholders shall register with a copy of their enterprise legal entity business license (with official seal), shareholder account card, and legal representative certificate. For attendance by proxy, the proxy must also present the legal representative's power of attorney and the proxy's own identity card for registration. (II) Internal employee share shareholders shall register with their own identity card and shareholder account card. For attendance by proxy, the proxy must also present the principal's power of attorney and the proxy's own identity card for registration. (III) Registration Location: Company Auditorium (Zhengqing Group, No. 288 Zhengqing Road, Huaihua City). (IV) Registration Time: February 5-6, 2010 (No registration will be processed after this period). IV. Meeting Time: 9:30 AM on February 7, 2010 (Saturday), for half a day. V. Meeting Location: Company Auditorium (Zhengqing Group, No. 288 Zhengqing Road, Huaihua City). VI. Other Matters: (I) Attendees' travel and accommodation expenses are self-borne. (II) Company Contacts: Zhang Guodong, Xiang Weiguo, Zhou Tingyan. (III) Company Contact Numbers: Huaihua 0745-2352540 (Yang Xiuchun, Peng Meitao, Li Jie) Changsha 0731-85226340 ext. (Qiu Qunying, Fu Rong) (IV) Company Contact Address: No. 288 Zhengqing Road, Huaihua City; Postal Code: 418000. 0745-2352068 (Huaihua Fax) 0731-85216892 (Changsha Fax) Board of Directors of Hunan Zhengqing Pharmaceutical Group Co., Ltd. January 20, 2010 Attachment: Power of Attorney Power of Attorney I hereby fully authorize Mr./Ms. _______ to represent me/my company at the First Extraordinary General Meeting of Shareholders for the year 2010 of Hunan Zhengqing Pharmaceutical Group Co., Ltd., and to exercise voting rights on my/our behalf. Principal: _______ Proxy: _______ Principal's Securities Account No.: _______ Proxy's ID Card No.: _______ Date of Authorization: _______ Number of Shares Held by Principal: _______ Signature of Principal: _______ Year Month Day

View Details

06

2014-06

Our company's equity confirmation work has officially begun.

In the early morning of June 19, 2014, although the sky was drizzling, it could not stop the steps of a crowd. Zhengqing Group, which had just moved to its new address, welcomed a large number of shareholders gathered from all directions, with the purpose of conducting on-site confirmation of Zhengqing shares. To improve and update shareholder information and lay a good foundation for the public transfer of the company's shares, our company will collaborate with relevant personnel from the Hunan Equity Registration and Management Center and Xieli Law Firm this year to conduct verification and on-site confirmation of shareholder equity information in cities with a high concentration of shareholders (Huaihua, Hengyang, Changsha). To ensure that the on-site confirmation process meets requirements and is rigorous, the company, Hunan Equity Registration and Management Center, and Xieli Law Firm had thoroughly discussed relevant on-site operation details before the meeting, ensuring that the on-site procedures, personnel division of labor, and work arrangements were all meticulously in place. Although shareholders continuously streamed into the Huaihua confirmation site on the 19th and 20th, with over 400 people, the order was well-maintained. The guiding group, pre-screening group, review group, and witnessing group all performed their respective duties, and the share confirmation work proceeded smoothly. The number of shareholder shares confirmed on-site in Huaihua exceeded expectations. However, some individuals were unable to process on-site confirmation due to non-conforming documents or information. Lawyers remind all shareholders to carefully read our company's 'Hunan Zhengqing Pharmaceutical Group Co., Ltd. Shareholder Information Verification and On-site Confirmation Announcement' (see www.zq99.com) before processing, and to prepare relevant materials as required by the announcement or make phone inquiries in advance before proceeding, to avoid missing the processing time. Shareholders who came to process were also very cooperative with the company's work, showing irrepressible excitement. Mr. Zhang, a shareholder, said, 'I was very happy to see the news about Zhengqing's equity confirmation. I got up early and rushed here. For so many years, I thought there was no hope, but Zhengqing has never given up on its listing efforts, which is very reassuring. Especially seeing the company's new plant and new appearance, I am even more confident in Zhengqing and look forward to Zhengqing bringing good news to shareholders soon.' Mr. Zhang Guodong, the company's Board Secretary, stated that with the relaxation of national policies, Zhengqing is actively planning its listing matters and introducing strategic investors through capital increase and share expansion. The initial focus is on fundamental work such as equity confirmation, and we hope to receive the cooperation of the majority of shareholders. The company will also strive to improve its internal capabilities, strengthen its foundation, enhance performance, and strive for an early listing to reward shareholders for their many years of perseverance! According to reports, equity confirmation work will next be processed on June 26 and 27 at Guotai Junan Business Department in Hengyang City, and on June 30 and July 1 at Hunan Equity Registration and Management Center in Changsha City. In addition, due to the large number of shareholders in Huaihua, to facilitate shareholders who have not yet undergone equity confirmation to process nearby, the company will add another session of shareholder equity information verification and on-site confirmation work in Huaihua in July (specific time to be determined). (Correspondent Qiu Qunying/Text)

View Details

06

2014-06

Announcement on Shareholder Information Verification and On-site Confirmation by Hunan Zhengqing Pharmaceutical Group Co., Ltd.

股东确权所需资料： （一） 股东信息核查须提供文件/信息清单（自然人股东） 请注意：1、以下清单中标“*”所示原件仅供审查之用，验完即退；2、同时具备两种及以上情形的，须同时提供所属各类情形所要求的文件。 1、 股东本人 （1）填写妥当的《股东信息核查表》(原件一份（格式见附表1，表格请于核查现场领取、填写）； （2）原湖南省证券登记公司发放的证券账户卡（黄卡）原件及一份复印件； （3）股东本人身份证原件*及一份复印件； （4）如委托他人代办，还需提供代办人身份证原件*及一份复印件，并提供经公证的授权委托书原件一份（格式见附表2）； 2、 股东死亡 （1）填写妥当的《股东信息核查表》原件一份（格式见附表1，表格请于核查现场领取、填写）； （2）原湖南省证券登记公司发放的证券账户卡（黄卡）原件及一份复印件； （3）股份继承人身份证原件*及一份复印件； （4）股东死亡证明原件*及一份复印件； （5）股份继承人与死亡股东的亲属关系证明原件*及一份复印件； （6）与股份有关的法院判决书、调解书等生效司法文书原件*及一份复印件、股份继承公证书原件等； 3、 股东离婚 （1）填写妥当的《股东信息核查表》原件一份（格式见附表1，表格请于核查现场领取、填写）； （2）原湖南省证券登记公司发放的证券账户卡（黄卡）原件及一份复印件； （3）分得股份的股东身份证原件*及一份复印件； （4）股东前配偶身份证原件*及一份复印件； （5）股东与前配偶夫妻（离婚）关系证明原件*及一份复印件； （6）与股份有关的法院判决书、调解书等生效司法文书原件*及一份复印件，或者经公证的财产分割协议原件等； 4、 股东被监禁 （1）股东本人签字的《股东信息核查表》原件一份（格式见附表1，表格请于核查现场领取、填写）； （2）原湖南省证券登记公司发放的证券账户卡（黄卡）原件及一份复印件； （3）股东本人身份证原件*及一份复印件，或劳教部门、监狱、公安部门出具的证明股东身份的文件原件； （4）股东被监禁证明原件*及一份复印件（如：人民法院判决书、执行通知书、收监通知书等）； （5）代办人身份证原件*及一份复印件，并提供经公证授权委托书原件一份（格式见附表2）； 5、 股东在海外定居、移民（包括港、澳、台地区） （1）填写妥当的《股东信息核查表》原件一份（格式见附表1，表格请于核查现场领取、填写）； （2）原湖南省证券登记公司发放的证券账户卡（黄卡）原件及一份复印件； （3）股东身份证明原件*及一份复印件，其中： n 外国人：护照、国籍证件； n 香港/澳门居民：永久性居民身份证；港澳同胞回乡证或者港澳居民来往内地通行证或者中华人民共和国香港/澳门特别行政区护照； n 台湾居民：台湾同胞旅行证或我国驻外使领馆签发的加注有“台湾同胞”字样的中华人民共和国旅行证。 （4）股东居住地公证机关公证书原件（证明股东姓名、国籍、职业、住址等），其中： n 外国人：公证书须由居住国外交部或由外交部指定的其他办理认证的官方机构和我国驻该地的使领馆认证； n 香港居民：由香港律师（即委托公证人）出具的，并由我国司法部派驻的“中国法律服务（香港）有限公司”加盖专用章确认的股东身份证明书； n 澳门居民：澳门特别行政区政府身份证明局出具的股东身份证明书； n 台湾居民：海峡交流基金会寄送的股东身份证明公证书； （5）如由他人代办，还需提供代办人身份证原件*及一份复印件，并提供经我国驻该地使领馆或受托律师、公证处认证/见证的授权委托书原件。 6、 股份转让 （1）由受让方填写妥当的《股东信息核查表》原件一份（格式见附表1，表格请于核查现场领取、填写）； （2）原湖南省证券登记公司发放的证券账户卡（黄卡）原件及一份复印件； （3）受让方身份证原件*及一份复印件； （4）经公证机关公证的、由买卖双方亲自签署的股份转让协议原件及公证书原件等。 （二） 股东信息核查须提供文件/信息清单（非自然人股东） 注：（1）以下清单中标“*”所示原件仅供审查之用，验完即退； （2）同时具备两种及以上情形的，须同时提供所属各类情形所要求的文件。 文件清单（复印件均须加盖公章） （1）填写妥当的《股东信息核查表（非自然人股东）原件一份（格式见附表3）； （2）原湖南省证券登记公司发放的证券账户卡（黄卡）原件及一份复印件； （3）通过最近一期年检的营业执照或事业单位法人证书或社团法人登记证书等非自然人股东登记证件的原件*及复印件一份； （4）组织机构代码证原件*及复印件一份； （5）经公证的授权委托书原件一份（格式见附表4）； （6）通过转让取得股份尚未办理过户手续的，还须提供经公证机关公证的、由买卖双方签署的股份转让协议原件及公证书原件等。 注： （1）如股权证上的股东名称与股东现行名称不一致，需填写《湖南正清制药集团股份有限公司股权持有人名册信息变更申请表（格式见附表5）》及提供相关证明文件，如历次更名文件、股权转让协议、改制批文、法院判决、股权划转文件等。 （2）如股东是不具备法人资格的分公司，需提供其母公司的相关资料。 （3）如股东所持公司股份存在质押、冻结、诉讼、仲裁、纠纷或潜在纠纷等情况，需提供情况说明和相关证明文件。 （4）如股东正处于改制阶段，除了提供证明资料外，还需提供改制进展情况说明。 （5）如股东正处于破产或清算程序，需提供法院或有关主管机关对其破产或清算出具的相关文件，以及清算组对公司破产或清算情况的简要说明。 （6）如股东已被吊销或注销，需提供工商局的吊销或注销文件，以及其持有公司股份被转让/拍卖/划转/抵债给他方的文件，公司股份的新受让方需提供证明资料。 （三） 其他情况特殊情况的处理 （1）自然人股东身份证遗失，可用临时身份证或户籍证明代替。 （2）自然人股东身份证上的姓名和证件号码任何一项发生变更，须持户籍所在地派出所出具的变更证明（证件号码由15位升至18位除外）需填写《湖南正清制药集团股份有限公司股权持有人名册信息变更申请表（格式见附表5）》。 （3）法人股东企业法人营业执照或事业单位法人证书或社会团体法人证书、组织机构代码证等主体资格证明文件原件遗失的，需提供由发证机关出具的有关主体资格证明文件。 （4）法人股东企业法人营业执照或事业单位法人证书或社会团体法人证书、组织机构代码证等主体资格证明文件机构名称和证件号码任何一项发生变更，须持发证机关出具的变更证明文件还需填写《湖南正清制药集团股份有限公司股权持有人名册信息变更申请表（格式见附表5）》。 （5）同一股东在股权持有人名册中存在多条持股记录的，需提供原湖南省证券登记公司发放的所有证券账户卡（黄卡）原件及复印件，同时填写《湖南正清制药集团股份有限公司股东股份记录合并申请表》（格式见附表6）。 （6）股东所持证券账户卡（黄卡）毁坏或遗失，自然股东还需由本人填写《挂失补办登记托管账户卡申请表》；法人股东需提供由法定代表人签章、公司盖章《挂失补办登记托管账户卡申请表》（格式见附表6）。 有关表格详见附件： 附表1：湖南正清制药集团股份有限公司股东信息核查表（自然人股东） 附表2：授权委托书（适用于自然人股东） 附表3：湖南正清制药集团股份有限公司股东信息核查表（非自然人股东） 附表4：授权委托书（适用于非自然人股东） 附表5：湖南正清制药集团股份有限公司股权持有人名册信息变更申请表 附表6：湖南正清制药集团股份有限公司股东股份记录合并申请表 附表7：挂失补办登记托管账户卡申请表 附表8：湖南正清制药集团股份有限公司股东股权确权回执

View Details